The Misuse of Drugs Act 1971 (Amendment) Order 2012

• Citation: S.I. 2012/1390
• Sections: 3

Section 1 Citation, commencement and interpretation

(1) This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2012 and shall come into force on the fourteenth day after the day on which it is made.

(2) In this Order “the 1971 Act ” means the Misuse of Drugs Act 1971.

Section 2 Amendments to the 1971 Act

In Part 2 of Schedule 2 to the 1971 Act (which specifies the drugs which are subject to control under that Act as Class B drugs)—

(a) after paragraph 1(ab), insert—

(ac) Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,

(i) by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;

(ii) by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;

(iii) by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.

(b) in paragraph 2A, for “paragraph 1(c)” substitute “paragraph 1(ac) or (c)”.

Section 3 Amendments to the 1971 Act

In Part 3 of Schedule 2 to the 1971 Act (which specifies the drugs which are subject to control under that Act as Class C drugs)—

(a) in paragraph 1(a)—

(i) omit “Pipradrol”; and

(ii) after “Bromazepam”, insert—

7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2 H -1,4-benzodiazepin-2-one.

(b) in paragraph 1(b), after “Oxymetholone.”, insert—

Pipradrol.